Literature DB >> 26316536

S-Nitrosylation Induces Both Autonomous Activation and Inhibition of Calcium/Calmodulin-dependent Protein Kinase II δ.

Jeffrey R Erickson1, C Blake Nichols2, Hitoshi Uchinoumi2, Matthew L Stein2, Julie Bossuyt2, Donald M Bers3.   

Abstract

NO is known to modulate calcium handling and cellular signaling in the myocardium, but key targets for NO in the heart remain unidentified. Recent reports have implied that NO can activate calcium/calmodulin (Ca(2+)/CaM)-dependent protein kinase II (CaMKII) in neurons and the heart. Here we use our novel sensor of CaMKII activation, Camui, to monitor changes in the conformation and activation of cardiac CaMKII (CaMKIIδ) activity after treatment with the NO donor S-nitrosoglutathione (GSNO). We demonstrate that exposure to NO after Ca(2+)/CaM binding to CaMKIIδ results in autonomous kinase activation, which is abolished by mutation of the Cys-290 site. However, exposure of CaMKIIδ to GSNO prior to Ca(2+)/CaM exposure strongly suppresses kinase activation and conformational change by Ca(2+)/CaM. This NO-induced inhibition was ablated by mutation of the Cys-273 site. We found parallel effects of GSNO on CaM/CaMKIIδ binding and CaMKIIδ-dependent ryanodine receptor activation in adult cardiac myocytes. We conclude that NO can play a dual role in regulating cardiac CaMKIIδ activity.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Ca2+/calmodulin-dependent protein kinase II (CaMKII); S-nitrosylation; nitric oxide; nitrosylation; protein kinase

Mesh:

Substances:

Year:  2015        PMID: 26316536      PMCID: PMC4646208          DOI: 10.1074/jbc.M115.650234

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  SparkMaster: automated calcium spark analysis with ImageJ.

Authors:  Eckard Picht; Aleksey V Zima; Lothar A Blatter; Donald M Bers
Journal:  Am J Physiol Cell Physiol       Date:  2007-03-21       Impact factor: 4.249

2.  Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure.

Authors:  Ralph J van Oort; Mark D McCauley; Sayali S Dixit; Laetitia Pereira; Yi Yang; Jonathan L Respress; Qiongling Wang; Angela C De Almeida; Darlene G Skapura; Mark E Anderson; Donald M Bers; Xander H T Wehrens
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

Review 3.  The multifunctional calcium/calmodulin-dependent protein kinase: from form to function.

Authors:  A P Braun; H Schulman
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

4.  Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes.

Authors:  Yanxia Li; Evangelia G Kranias; Gregory A Mignery; Donald M Bers
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

5.  Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo.

Authors:  Yingbo Yang; Wei-Zhong Zhu; Mei-ling Joiner; Rong Zhang; Carmine V Oddis; Yue Hou; Jinying Yang; Edward E Price; Linda Gleaves; Mesut Eren; Gemin Ni; Douglas E Vaughan; Rui-Ping Xiao; Mark E Anderson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-07-21       Impact factor: 4.733

6.  Ca2+/Calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes.

Authors:  Tao Guo; Tong Zhang; Ruben Mestril; Donald M Bers
Journal:  Circ Res       Date:  2006-07-13       Impact factor: 17.367

7.  Cardiac myocyte Z-line calmodulin is mainly RyR2-bound, and reduction is arrhythmogenic and occurs in heart failure.

Authors:  Yi Yang; Tao Guo; Tetsuro Oda; Asima Chakraborty; Le Chen; Hitoshi Uchinoumi; Anne A Knowlton; Bradley R Fruen; Razvan L Cornea; Gerhard Meissner; Donald M Bers
Journal:  Circ Res       Date:  2013-11-01       Impact factor: 17.367

8.  Mechanochemotransduction during cardiomyocyte contraction is mediated by localized nitric oxide signaling.

Authors:  Zhong Jian; Huilan Han; Tieqiao Zhang; Jose Puglisi; Leighton T Izu; John A Shaw; Ekama Onofiok; Jeffery R Erickson; Yi-Je Chen; Balazs Horvath; Rafael Shimkunas; Wenwu Xiao; Yuanpei Li; Tingrui Pan; James Chan; Tamas Banyasz; Jil C Tardiff; Nipavan Chiamvimonvat; Donald M Bers; Kit S Lam; Ye Chen-Izu
Journal:  Sci Signal       Date:  2014-03-18       Impact factor: 8.192

9.  Intracellular signalling mechanism responsible for modulation of sarcolemmal ATP-sensitive potassium channels by nitric oxide in ventricular cardiomyocytes.

Authors:  Dai-Min Zhang; Yongping Chai; Jeffrey R Erickson; Joan Heller Brown; Donald M Bers; Yu-Fung Lin
Journal:  J Physiol       Date:  2013-11-25       Impact factor: 5.182

10.  Nitric oxide-dependent activation of CaMKII increases diastolic sarcoplasmic reticulum calcium release in cardiac myocytes in response to adrenergic stimulation.

Authors:  Jerry Curran; Lifei Tang; Steve R Roof; Sathya Velmurugan; Ashley Millard; Stephen Shonts; Honglan Wang; Demetrio Santiago; Usama Ahmad; Matthew Perryman; Donald M Bers; Peter J Mohler; Mark T Ziolo; Thomas R Shannon
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more
  41 in total

Review 1.  CaM Kinase: Still Inspiring at 40.

Authors:  K Ulrich Bayer; Howard Schulman
Journal:  Neuron       Date:  2019-08-07       Impact factor: 17.173

Review 2.  Research progress on the role of CaMKII in heart disease.

Authors:  Shi-Jun Jiang; Wei Wang
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

3.  β-Adrenergic induced SR Ca2+ leak is mediated by an Epac-NOS pathway.

Authors:  Laëtitia Pereira; Dan J Bare; Samuel Galice; Thomas R Shannon; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2017-05-02       Impact factor: 5.000

4.  Hyperglycemia Acutely Increases Cytosolic Reactive Oxygen Species via O-linked GlcNAcylation and CaMKII Activation in Mouse Ventricular Myocytes.

Authors:  Shan Lu; Zhandi Liao; Xiyuan Lu; Dörthe M Katschinski; Mark Mercola; Ju Chen; Joan Heller Brown; Jeffery D Molkentin; Julie Bossuyt; Donald M Bers
Journal:  Circ Res       Date:  2020-03-05       Impact factor: 17.367

Review 5.  Oxidant stress promotes disease by activating CaMKII.

Authors:  Mark E Anderson
Journal:  J Mol Cell Cardiol       Date:  2015-10-22       Impact factor: 5.000

6.  Improvement of cardiomyocyte function by a novel pyrimidine-based CaMKII-inhibitor.

Authors:  Stefan Neef; Alexander Steffens; Patricia Pellicena; Julian Mustroph; Simon Lebek; Katharina R Ort; Howard Schulman; Lars S Maier
Journal:  J Mol Cell Cardiol       Date:  2017-12-30       Impact factor: 5.000

7.  Alamandine enhances cardiomyocyte contractility in hypertensive rats through a nitric oxide-dependent activation of CaMKII.

Authors:  Itamar Couto Guedes Jesus; Thássio Ricardo Ribeiro Mesquita; André Luís Lima Monteiro; Amanda Borges Parreira; Anderson Kenedy Santos; Elizeu Lucas Xavier Coelho; Mário Morais Silva; Lucas A C Souza; Maria José Campagnole-Santos; Robson Souza Santos; Silvia Guatimosim
Journal:  Am J Physiol Cell Physiol       Date:  2020-01-08       Impact factor: 4.249

8.  Cardiac CaMKII activation promotes rapid translocation to its extra-dyadic targets.

Authors:  Brent M Wood; Mitchell Simon; Samuel Galice; Chidera C Alim; Maura Ferrero; Natalie N Pinna; Donald M Bers; Julie Bossuyt
Journal:  J Mol Cell Cardiol       Date:  2018-10-12       Impact factor: 5.000

9.  Muscarinic-dependent phosphorylation of the cardiac ryanodine receptor by protein kinase G is mediated by PI3K-AKT-nNOS signaling.

Authors:  Stephen Baine; Justin Thomas; Ingrid Bonilla; Marina Ivanova; Andriy Belevych; Jiaoni Li; Rengasayee Veeraraghavan; Przemyslaw B Radwanski; Cynthia Carnes; Sandor Gyorke
Journal:  J Biol Chem       Date:  2020-06-24       Impact factor: 5.157

10.  Non-ion channel therapeutics for heart failure and atrial fibrillation: Are CaMKII inhibitors ready for clinical use?

Authors:  Eleonora Grandi; Dobromir Dobrev
Journal:  J Mol Cell Cardiol       Date:  2017-10-25       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.